The global In Vitro Gene Therapy market growth is projected to reach US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global In Vitro Gene Therapy Market Trends And Outlook 2025-31

The global In Vitro Gene Therapy market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. United States market for In Vitro Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for In Vitro Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for In Vitro Gene Therapy is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key In Vitro Gene Therapy players cover Orchard Therapeutics, Kolon Pharma, bluebird bio, Novartis, GILD (Kite Pharma), etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. LPI (LP Information) newest research report, the ?In Vitro Gene Therapy Industry Forecast? looks at past sales and reviews total world In Vitro Gene Therapy sales in 2024, providing a comprehensive analysis by region and market sector of projected In Vitro Gene Therapy sales for 2025 through 2031. With In Vitro Gene Therapy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world In Vitro Gene Therapy industry. This Insight Report provides a comprehensive analysis of the global In Vitro Gene Therapy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on In Vitro Gene Therapy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global In Vitro Gene Therapy market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for In Vitro Gene Therapy and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global In Vitro Gene Therapy. This report presents a comprehensive overview, market shares, and growth opportunities of In Vitro Gene Therapy market by product type, application, key players and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; CAR-T &nbsp;&nbsp;&nbsp; CRISPR Segmentation by Application: &nbsp;&nbsp;&nbsp; Hospital &nbsp;&nbsp;&nbsp; Specialty Clinic &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Orchard Therapeutics &nbsp;&nbsp;&nbsp; Kolon Pharma &nbsp;&nbsp;&nbsp; bluebird bio &nbsp;&nbsp;&nbsp; Novartis &nbsp;&nbsp;&nbsp; GILD (Kite Pharma) &nbsp;&nbsp;&nbsp; Bristol Myers Squibb &nbsp;&nbsp;&nbsp; JW Therapeutics

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global In Vitro Gene Therapy Market Size (2020-2031) &nbsp;2.1.2 In Vitro Gene Therapy Market Size CAGR by Region (2020 VS 2024 VS 2031) &nbsp;2.1.3 World Current & Future Analysis for In Vitro Gene Therapy by Country/Region (2020, 2024 & 2031) &nbsp;2.2 In Vitro Gene Therapy Segment by Type &nbsp;2.2.1 CAR-T &nbsp;2.2.2 CRISPR &nbsp;2.3 In Vitro Gene Therapy Market Size by Type &nbsp;2.3.1 In Vitro Gene Therapy Market Size CAGR by Type (2020 VS 2024 VS 2031) &nbsp;2.3.2 Global In Vitro Gene Therapy Market Size Market Share by Type (2020-2025) &nbsp;2.4 In Vitro Gene Therapy Segment by Application &nbsp;2.4.1 Hospital &nbsp;2.4.2 Specialty Clinic &nbsp;2.4.3 Others &nbsp;2.5 In Vitro Gene Therapy Market Size by Application &nbsp;2.5.1 In Vitro Gene Therapy Market Size CAGR by Application (2020 VS 2024 VS 2031) &nbsp;2.5.2 Global In Vitro Gene Therapy Market Size Market Share by Application (2020-2025) 3 In Vitro Gene Therapy Market Size by Player &nbsp;3.1 In Vitro Gene Therapy Market Size Market Share by Player &nbsp;3.1.1 Global In Vitro Gene Therapy Revenue by Player (2020-2025) &nbsp;3.1.2 Global In Vitro Gene Therapy Revenue Market Share by Player (2020-2025) &nbsp;3.2 Global In Vitro Gene Therapy Key Players Head office and Products Offered &nbsp;3.3 Market Concentration Rate Analysis &nbsp;3.3.1 Competition Landscape Analysis &nbsp;3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.4 New Products and Potential Entrants &nbsp;3.5 Mergers & Acquisitions, Expansion 4 In Vitro Gene Therapy by Region &nbsp;4.1 In Vitro Gene Therapy Market Size by Region (2020-2025) &nbsp;4.2 Global In Vitro Gene Therapy Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas In Vitro Gene Therapy Market Size Growth (2020-2025) &nbsp;4.4 APAC In Vitro Gene Therapy Market Size Growth (2020-2025) &nbsp;4.5 Europe In Vitro Gene Therapy Market Size Growth (2020-2025) &nbsp;4.6 Middle East & Africa In Vitro Gene Therapy Market Size Growth (2020-2025) 5 Americas &nbsp;5.1 Americas In Vitro Gene Therapy Market Size by Country (2020-2025) &nbsp;5.2 Americas In Vitro Gene Therapy Market Size by Type (2020-2025) &nbsp;5.3 Americas In Vitro Gene Therapy Market Size by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC In Vitro Gene Therapy Market Size by Region (2020-2025) &nbsp;6.2 APAC In Vitro Gene Therapy Market Size by Type (2020-2025) &nbsp;6.3 APAC In Vitro Gene Therapy Market Size by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia 7 Europe &nbsp;7.1 Europe In Vitro Gene Therapy Market Size by Country (2020-2025) &nbsp;7.2 Europe In Vitro Gene Therapy Market Size by Type (2020-2025) &nbsp;7.3 Europe In Vitro Gene Therapy Market Size by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa In Vitro Gene Therapy by Region (2020-2025) &nbsp;8.2 Middle East & Africa In Vitro Gene Therapy Market Size by Type (2020-2025) &nbsp;8.3 Middle East & Africa In Vitro Gene Therapy Market Size by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Global In Vitro Gene Therapy Market Forecast &nbsp;10.1 Global In Vitro Gene Therapy Forecast by Region (2026-2031) &nbsp;10.1.1 Global In Vitro Gene Therapy Forecast by Region (2026-2031) &nbsp;10.1.2 Americas In Vitro Gene Therapy Forecast &nbsp;10.1.3 APAC In Vitro Gene Therapy Forecast &nbsp;10.1.4 Europe In Vitro Gene Therapy Forecast &nbsp;10.1.5 Middle East & Africa In Vitro Gene Therapy Forecast &nbsp;10.2 Americas In Vitro Gene Therapy Forecast by Country (2026-2031) &nbsp;10.2.1 United States Market In Vitro Gene Therapy Forecast &nbsp;10.2.2 Canada Market In Vitro Gene Therapy Forecast &nbsp;10.2.3 Mexico Market In Vitro Gene Therapy Forecast &nbsp;10.2.4 Brazil Market In Vitro Gene Therapy Forecast &nbsp;10.3 APAC In Vitro Gene Therapy Forecast by Region (2026-2031) &nbsp;10.3.1 China In Vitro Gene Therapy Market Forecast &nbsp;10.3.2 Japan Market In Vitro Gene Therapy Forecast &nbsp;10.3.3 Korea Market In Vitro Gene Therapy Forecast &nbsp;10.3.4 Southeast Asia Market In Vitro Gene Therapy Forecast &nbsp;10.3.5 India Market In Vitro Gene Therapy Forecast &nbsp;10.3.6 Australia Market In Vitro Gene Therapy Forecast &nbsp;10.4 Europe In Vitro Gene Therapy Forecast by Country (2026-2031) &nbsp;10.4.1 Germany Market In Vitro Gene Therapy Forecast &nbsp;10.4.2 France Market In Vitro Gene Therapy Forecast &nbsp;10.4.3 UK Market In Vitro Gene Therapy Forecast &nbsp;10.4.4 Italy Market In Vitro Gene Therapy Forecast &nbsp;10.4.5 Russia Market In Vitro Gene Therapy Forecast &nbsp;10.5 Middle East & Africa In Vitro Gene Therapy Forecast by Region (2026-2031) &nbsp;10.5.1 Egypt Market In Vitro Gene Therapy Forecast &nbsp;10.5.2 South Africa Market In Vitro Gene Therapy Forecast &nbsp;10.5.3 Israel Market In Vitro Gene Therapy Forecast &nbsp;10.5.4 Turkey Market In Vitro Gene Therapy Forecast &nbsp;10.6 Global In Vitro Gene Therapy Forecast by Type (2026-2031) &nbsp;10.7 Global In Vitro Gene Therapy Forecast by Application (2026-2031) &nbsp;10.7.1 GCC Countries Market In Vitro Gene Therapy Forecast 11 Key Players Analysis &nbsp;11.1 Orchard Therapeutics &nbsp;11.1.1 Orchard Therapeutics Company Information &nbsp;11.1.2 Orchard Therapeutics In Vitro Gene Therapy Product Offered &nbsp;11.1.3 Orchard Therapeutics In Vitro Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.1.4 Orchard Therapeutics Main Business Overview &nbsp;11.1.5 Orchard Therapeutics Latest Developments &nbsp;11.2 Kolon Pharma &nbsp;11.2.1 Kolon Pharma Company Information &nbsp;11.2.2 Kolon Pharma In Vitro Gene Therapy Product Offered &nbsp;11.2.3 Kolon Pharma In Vitro Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.2.4 Kolon Pharma Main Business Overview &nbsp;11.2.5 Kolon Pharma Latest Developments &nbsp;11.3 bluebird bio &nbsp;11.3.1 bluebird bio Company Information &nbsp;11.3.2 bluebird bio In Vitro Gene Therapy Product Offered &nbsp;11.3.3 bluebird bio In Vitro Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.3.4 bluebird bio Main Business Overview &nbsp;11.3.5 bluebird bio Latest Developments &nbsp;11.4 Novartis &nbsp;11.4.1 Novartis Company Information &nbsp;11.4.2 Novartis In Vitro Gene Therapy Product Offered &nbsp;11.4.3 Novartis In Vitro Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.4.4 Novartis Main Business Overview &nbsp;11.4.5 Novartis Latest Developments &nbsp;11.5 GILD (Kite Pharma) &nbsp;11.5.1 GILD (Kite Pharma) Company Information &nbsp;11.5.2 GILD (Kite Pharma) In Vitro Gene Therapy Product Offered &nbsp;11.5.3 GILD (Kite Pharma) In Vitro Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.5.4 GILD (Kite Pharma) Main Business Overview &nbsp;11.5.5 GILD (Kite Pharma) Latest Developments &nbsp;11.6 Bristol Myers Squibb &nbsp;11.6.1 Bristol Myers Squibb Company Information &nbsp;11.6.2 Bristol Myers Squibb In Vitro Gene Therapy Product Offered &nbsp;11.6.3 Bristol Myers Squibb In Vitro Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.6.4 Bristol Myers Squibb Main Business Overview &nbsp;11.6.5 Bristol Myers Squibb Latest Developments &nbsp;11.7 JW Therapeutics &nbsp;11.7.1 JW Therapeutics Company Information &nbsp;11.7.2 JW Therapeutics In Vitro Gene Therapy Product Offered &nbsp;11.7.3 JW Therapeutics In Vitro Gene Therapy Revenue, Gross Margin and Market Share (2020-2025) &nbsp;11.7.4 JW Therapeutics Main Business Overview &nbsp;11.7.5 JW Therapeutics Latest Developments 12 Research Findings and Conclusion

Report	Global In Vitro Gene Therapy Market Growth (Status and Outlook) 2025-2031
Selected License	Single ID:LPI10806

Buyer Information

Order Summary